Efficacy and long-term safety of a dengue vaccine in regions of endemic disease
Copyright © 2015 Massachusetts Medical Society. Background: A candidate tetravalent dengue vaccine is being assessed in three clinical trials involving more than 35,000 children between the ages of 2 and 16 years in Asian-Pacific and Latin American countries. We report the results of long-term follo...
Saved in:
Main Authors: | S. R. Hadinegoro, J. L. Arredondo-García, M. R. Capeding, C. Deseda, T. Chotpitayasunondh, R. Dietze, H. I. Hj Muhammad Ismail, H. Reynales, K. Limkittikul, D. M. Rivera-Medina, H. N. Tran, A. Bouckenooghe, D. Chansinghakul, M. Cortés, K. Fanouillere, R. Forrat, C. Frago, S. Gailhardou, N. Jackson, F. Noriega, E. Plennevaux, T. A. Wartel, B. Zambrano, M. Saville |
---|---|
Other Authors: | University of Indonesia, RSUPN Dr. Cipto Mangunkusumo |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/36320 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America
by: J. L. Arredondo-García, et al.
Published: (2019) -
Long-term safety follow-up of children from a randomized - Controlled phase II b proof - Of - concept efficacy study of the live, attenuated, tetravalent dengue vaccine (CYD - TDV) in Thailand
by: Kriengsak Limkittikul, et al.
Published: (2020) -
Detection of dengue cases by serological testing in a dengue vaccine efficacy trial: Utility for efficacy evaluation and impact of future vaccine introduction
by: Eric Plennevaux, et al.
Published: (2018) -
Serological Evidence of Japanese Encephalitis Virus Circulation in Asian Children From Dengue-Endemic Countries
by: Joshua Nealon, et al.
Published: (2020) -
Impact of Dengue Vaccination on Serological Diagnosis: Insights from Phase III Dengue Vaccine Efficacy Trials
by: Eric Plennevaux, et al.
Published: (2019)